Compounds > cyclohexanol

Page last updated: 2024-08-18

cyclohexanol and Neuroleptic Malignant Syndrome

cyclohexanol has been researched along with Neuroleptic Malignant Syndrome in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boncompagni, G; Ferioli, V; Manes, A; Melloni, C; Nanni, S	1
Dunewicz, M; Grégoire, G; Précourt, A; Williamson, DR	1
Bilbao-Garay, J; de Lucas-Taracena, MT; Montañes-Rada, F; Ortiz-Ortiz, ME	1
Chen, WJ; Chu, PL; Lu, TC; Tsai, KC; Wu, CS	1
Atkin, SL; Nimmagadda, SR; Ryan, DH	1
Cassidy, EM; O'Kearne, V	1

Other Studies

6 other study(ies) available for cyclohexanol and Neuroleptic Malignant Syndrome

Article	Year
Atypical neuroleptic malignant syndrome caused by clozapine and venlafaxine: early brief treatment with dantrolene. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2004, Volume: 49, Issue:7 Topics: Adult; Clozapine; Cyclohexanols; Dantrolene; GABA Antagonists; Humans; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride	2004
Multiple complications and withdrawal syndrome associated with quetiapine/venlafaxine intoxication. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:1 Topics: Coma; Cyclohexanols; Diagnosis, Differential; Dibenzothiazepines; Drug Overdose; Electrocardiography; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Quetiapine Fumarate; Respiratory Insufficiency; Seizures; Serotonin Agents; Serotonin Syndrome; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2005
Venlafaxine, serotonin syndrome, and differential diagnoses. Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Catatonia; Cyclohexanols; Diagnosis, Differential; Female; Humans; Neuroleptic Malignant Syndrome; Serotonin Syndrome; Venlafaxine Hydrochloride	2005
Neuroleptic malignant syndrome after the use of venlafaxine in a patient with generalized anxiety disorder. Journal of the Formosan Medical Association = Taiwan yi zhi, 2006, Volume: 105, Issue:1 Topics: Aged; Anxiety Disorders; Cyclohexanols; Humans; Male; Neuroleptic Malignant Syndrome; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2006
Neuroleptic malignant syndrome after venlafaxine. Lancet (London, England), 2000, Jan-22, Volume: 355, Issue:9200 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Dopamine Antagonists; Drug Interactions; Drug Therapy, Combination; Humans; Male; Neuroleptic Malignant Syndrome; Trifluoperazine; Venlafaxine Hydrochloride	2000
Neuroleptic malignant syndrome after venlafaxine. Lancet (London, England), 2000, Jun-17, Volume: 355, Issue:9221 Topics: Animals; Cyclohexanols; Humans; Neuroleptic Malignant Syndrome; Rats; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2000